Latest MS research news

Latest MS research news | 04 February 2014

Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

This study investigated if the serum levels of apolipoproteins (which are types of proteins involved in cholesterol regulation) measured prior to starting disease modifying therapy were associated with disease progression

From MSIF

Latest MS research news | 04 February 2014

Pregnancy outcomes in the clinical development program of fingolimod in MS

This study reports the outcomes of women with unplanned pregnancies who enrolled in fingolimod (new oral treatment available in relapsing remitting MS) clinical trials.

From MSIF

Latest MS research news | 04 February 2014

Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of MS

Urinary tract symptoms are common in MS, with a significant negative impact on quality of life. This study demonstrated that patients with clinically isolated syndrome (CIS) had a higher prevalence of urinary symptoms.

From MSIF

Latest MS research news | 28 January 2014

Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS

This study looked at particular types of immune cells (T cells), which are known to cause injury to the central nervous system in RRMS, although their role in SPMS is not clear. The researchers found that there were differences in the cell biology of these T cells, which identified patients with MS having different rates of development of secondary progression.

From MSIF

Latest MS research news | 28 January 2014

Modest familial risks for MS: a registry-based study of the population of Sweden

MS is a complex disease with more than one hundred risk associated genes identified to date. This study looked at the familial recurrence risks of MS. Overall the results demonstrated lower risk ratios than most previous studies of familial recurrences in multiple sclerosis to date.

From MSIF

Latest MS research news | 28 January 2014

Safety and efficacy of ofatumumab in relapsing-remitting MS: A phase 2 study

This clinical trial looked at ofatumumab in patients with relapsing remitting MS, to assess both the safety and the efficacy of the drug.

From MSIF

Latest MS research news | 21 January 2014

Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions

In this study the researchers quantified this neurotransmitter (glutamate) in specific regions of the brain and investigated if there was a relationship between the concentration of this neurotransmitter and memory performance in subjects with relapsing-remitting MS.

From MSIF

Latest MS research news | 21 January 2014

Immunotherapies influence the influenza vaccination response in MS patients: an explorative study

The researchers in this study demonstrated that MS patients receiving immunomodulatory therapy (glatiramer acetate, natalizumab and mitoxantrone) had a reduced rate of protection to the seasonal influenza vaccine. Patients receiving interferon therapy did not demonstrate reduced protection.

From MSIF

Latest MS research news | 21 January 2014

Intervention for increasing exercise behaviour and improving health outcomes

This study demonstrates improvements in self-directed exercise behaviour, health related quality of life and fatigue.

From MSIF

Latest MS research news | 14 January 2014

Motor and sensory responses after percutaneous tibial nerve stimulation in MS patients with lower urinary tract symptoms

This study looked at the use of posterior tibial nerve stimulation (PTNS) in MS subjects unresponsive to medical treatment.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research